10229 N Scottsdale Rd B, Scottsdale, AZ(480) 863-5533Tue–Sat 10am–6pm · Sun & Mon Closed

Resources & News

All of the latest news, studies and research in weight loss and regenerative medicine.

In the News

Weight Loss News & Research

Oprah Winfrey Reveals She Uses Weight-Loss Drugs, Calls It a “Gift”

Video on YouTube

Oprah Winfrey Reveals She Uses Weight-Loss Drugs, Calls It a “Gift”

Oprah revealed she uses a weight-loss drug as part of her health routine. NBC’s Emilie Ikeda reports and Dr. Roshini Raj joins TODAY on how Winfrey is helping lift the shame of treating obesity.

Read more →
Eli Lilly’s Zepbound Beats Novo Nordisk’s Wegovy in First Head-to-Head Study

Research

Eli Lilly’s Zepbound Beats Novo Nordisk’s Wegovy in First Head-to-Head Study

People taking Zepbound lost 20.2% of their body weight on average after 72 weeks, compared with 13.7% for Wegovy patients — translating to an average 50-pound loss vs. 33 pounds.

Read more →
Oprah Winfrey Opens Up About Exiting Weight Watchers After Using Weight-Loss Drug

USA Today

Oprah Winfrey Opens Up About Exiting Weight Watchers After Using Weight-Loss Drug

In a March 2024 ABC special, Oprah delved into the rising use of weight loss drugs like Ozempic, discussing benefits and potential risks with medical experts.

Read more →
How Do GLP-1 Agonists Help with Inflammation?

Conscien Health

How Do GLP-1 Agonists Help with Inflammation?

GLP-1 agonists exhibit anti-inflammatory properties beyond managing blood sugar. Research published in Cell Metabolism indicates they can influence brain signaling pathways that suppress inflammation in other body regions.

Read more →
Novo Nordisk’s Wegovy Wins FDA Approval for Cutting Heart Disease Risks

CNBC

Novo Nordisk’s Wegovy Wins FDA Approval for Cutting Heart Disease Risks

In March 2024, the FDA approved Wegovy for reducing major adverse cardiovascular events. The SELECT trial of 17,600+ participants showed a 20% reduction in such events vs. placebo.

Read more →
Could a Diabetes Drug Be a Game Changer for Weight Loss?

Video on YouTube

Could a Diabetes Drug Be a Game Changer for Weight Loss?

Dr. Oz sits down with leading obesity researcher Dr. Robert Kushner to discuss a 68-week clinical trial where GLP-1s helped participants lose an average of 15% of their body weight.

Read more →

Have Questions About These Treatments?

Our doctors can help you understand which medically-supervised options are right for you. Book a free consultation today.

Call (480) 863-5533